Abstract
DC BeadTM is a FDA cleared embolisation device for the treatment of hypervascular tumours and arteriovenous malformations. This product is currently evaluated in a number of centres in Europe as an embolic device for transarterial chemoembolisation (TACE). The beads consist of poly(vinyl alcohol) microspheres modified with sulfonic acid groups and are available at different size ranges varying from 100 to 900 μm in diameter. The beads were shown to actively sequester doxorubicin hydrochloride (dox) from solution in a time dependent upon the dose of the drug and size of the beads. Drug uptake was by an ion-exchange mechanism, and in the absence of other ions in solution, the beads could load a maximum of around 40 mg dox/mL hydrated beads, with >99% of drug being sequestered from the solution. A loading of 25 mg dox/mL beads was recommended as providing a practical therapeutic dose and optimum handling characteristics. There was a decrease in equilibrium water content of the beads with increasing dox loading, which resulted in a decrease in the average diameter of the beads and an increase in the compressive modulus. The deliverability properties, however, were not affected after drug loading. Using a variety of microscopic methods, the drug was shown to be distributed throughout the bead structure, but concentrated in the outer 20 μm surface layer, a feature related to the method of synthesis. This study characterises the properties of DC Bead loaded with dox with respect to important characteristics in embolisation and demonstrates the potential of this drug device combination for the treatment of hypervascular tumours such as hepatocellular carcinoma.
Similar content being viewed by others
References
J. M. LLOVET, J. Gastroenterol. 40(3) (2005) 225
J. BRUIX, M. SALA and J. LLOVET, Gastroenterology 127(5 Suppl 1) (2004) S179
J. M. LLOVET, M. I. REAL, X. MONTAŇA, et al., Lancet 359 (2002) 1734
C-M. LO, H. NGAN, W-K. TSO, et al., Hepatology 35 (2002) 1164
M. S. CHEN, J. Q. LI, Y. Q. ZHANG, et al., World. J. Gastroenterol. 8(1) (2002) 74
A. L. LEWIS and M. J. DRIVER, Eur. Biophram. Rev. (Summer) (2005) 82
A. L. LEWIS, M. V. GONZALEZ, A. W. LLOYD, et al., JVIR 17(2) (2006) 335
D. J. KERR and S. B. KAYE, Crit. Rev. Ther. Drug Carrier Syst. 8(1) (1991) 19
P. M. J. FLANDROY, C. GRANDFILS and R. J. JEROME, Pharmaceutical particulate carriers: Therapeutic applications, edited by A. Rolland (Marcel Dekker Inc: New York 1993) p. 321
A. LAMRECHT, H. YAMAMOTO, H. TAKEUCHI and Y. KAWASHIMA, J. Control Release 90(3) (2003) 313
H. R. MORRIS, C. C. HOYT and P. J. TREADO, Appl. Spectrosc. 48(7) (1994) 857
A. L. LEWIS, C. ADAMS, W. BUSBY, et al., J. Mater. Sci: Mater. Med. 17 (2006) 1193
Personal communications with J.Bruix, the Barcelona Clinic for Liver Cancer, Barcelona, Spain
E. A. LEFRAK, J. PITHA, S. ROSENHEIM and J. A. GOTTLIEB, Cancer 32 (1973) 302
Z. LIU, R. CHEUNG, X. Y. WU, et al., J. Control Release 77 (2001) 213
W-I. CHA, S-H. HYON, O. MASANORI and Y. IKADA, Mechanical and wear properties of poly(vinyl alcohol) hydrogels, Macromolecular Symposia 109 (36th Microsymposium on Macromolecules High-Swelling Gels, 1995) (1996) 115
D. W. GOUPIL, H. HASSAN, T. HOLLAND, et al., Embolic compositions comprising polymers with a diol structure unit. WO 2001068720 (Biocure Inc)
M. V. GONZALEZ, Y. TANG, G. J. PHILLIPS, et al., J. Mater. Sci: Mater. Med. in press
Acknowledgments
VG would like to thank Biocompatibles UK Ltd for funding her PhD. Thanks also to Dr. Simon Fitzgerald, from LabRam Laboratories, for use of the Raman Fluorescent Microscope and Dr. Jin Hai Wang, from Biocompatibles UK Ltd, for use of the fluorescent microscope.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lewis, A.L., Gonzalez, M.V., Leppard, S.W. et al. Doxorubicin eluting beads − 1: Effects of drug loading on bead characteristics and drug distribution. J Mater Sci: Mater Med 18, 1691–1699 (2007). https://doi.org/10.1007/s10856-007-3068-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-007-3068-8